The multidisciplinary research team employed advanced microscopy techniques to explore the physical and functional nature of contacts between SCLC cells and neurons. Using co-culture systems involving SCLC cells and cortical neurons, investigators applied immunostaining targeting glutamatergic vesicles, specifically using antibodies against vesicular glutamate transporter 1 (VGluT1), and postsynaptic scaffold protein HOMER1. This approach revealed closely juxtaposed puncta indicative of synaptic-like formations directly at the interface of neurons and cancer cells, a phenomenon rarely documented in non-neuronal malignancies.

To ascertain whether these observations extended beyond one experimental model, the researchers utilized human induced pluripotent stem (iPS) cell-derived cortical neurons. These cultures demonstrated consistent synaptic marker colocalization, marked by presynaptic expression of Bassoon in neurons and postsynaptic localization of HOMER1 within SCLC cells. This cross-validation across species and cellular models reinforces the hypothesis of neuron-to-cancer cell synaptic communication.

Further validating the anatomical and physiological relevance of these synapses, the team incorporated mouse nodose ganglia into co-cultures. This peripheral nervous system cluster is known to innervate pulmonary neuroendocrine cells (PNECs), posited as the origin of VGluT1-positive fibers identified in vivo within tumors. Imaging revealed continued juxtaposition of presynaptic VGluT1 and postsynaptic HOMER1 within SCLC cells, confirming that circuits resembling canonical synapses can form under diverse biological contexts.

Transitioning from in vitro systems to in vivo settings, the researchers examined brain allografts containing SCLC cells expressing fluorescent markers. Confocal and electron microscopy analyses identified HOMER1-positive postsynaptic structures in close proximity to axonal boutons labeled by enhanced green fluorescent protein (eGFP), signs of functional synapses. Lung tissue sections from genetically engineered, Cre-exposed RP mice revealed similar contacts at tumor margins, demonstrating that synapse-like interfaces between neurons and cancer cells occur naturally in complex tissue environments.

To achieve nanoscale resolution necessary for definitive structural characterization, the study employed tenfold expansion microscopy (x10ht), attaining spatial resolution near 25 nanometers. Three-dimensional reconstructions of cortical neuron–SCLC co-cultures revealed the spatial organization of presynaptic VGluT1-positive puncta positioned adjacent to postsynaptic HOMER1 immunoreactivity in cancer cells. This spatial fidelity is consistent with the nanometer-scale architecture of classical excitatory synapses in the central nervous system.

To push resolution boundaries further, the investigators applied one-step nanoscale expansion (ONE) microscopy, a super-resolution technique affording even finer visualization of synaptic components. Both three-dimensional and two-dimensional imaging modalities highlighted clear segregation of pre- and postsynaptic elements. Quantitative measurements revealed that the physical distance between VGluT1 and HOMER1 puncta at neuron–cancer cell contacts mirrored that observed at established neuron–neuron synapses within the same cultures, strengthening the assertion of synaptic conformity.

Correlative light and electron microscopy (CLEM), integrating high-resolution fluorescence imaging with ultrastructural analysis, constituted a pivotal validation strategy. Electron tomograms of fluorescently labeled SCLC cells in brain allografts revealed presynaptic boutons densely packed with synaptic vesicles in direct contact with cancer cell membranes. The presence of clearly defined synaptic clefts and vesicle pools within 20 nanometers from the presynaptic membrane echoed canonical synapse ultrastructure, affirming the authenticity of these specialized cell junctions.

A systematic examination of 280 cell perimeters at the periphery of the cancer allografts indicated that approximately 8.2% of SCLC cells formed synapses with axonal boutons, a substantial proportion given the heterogeneity of tumor microenvironments. This prevalence underscores the biological significance of these synaptic interactions and suggests potential roles in tumor progression, neuro-immune modulation, or therapeutic resistance mechanisms.

The discovery of synaptic connections between neural axons and SCLC cells challenges the traditional view of tumor biology as an exclusively cell-autonomous process, highlighting instead a dynamic neuro-cancer interface that may influence cancer cell behavior. Such functional synapses could mediate bidirectional communication, enabling neurons to modulate cancer cell signaling pathways and, reciprocally, cancer cells to influence neuronal circuitry.

Beyond structural characterization, these findings prompt intriguing questions regarding the nature of synaptic transmission between neurons and SCLC cells. Functional assays addressing whether neurotransmitter release at these synapses affects cancer proliferation, survival, or metastatic potential could expand understanding of how neuronal inputs integrate into tumor biology.

Moreover, this research paves the way for exploring synaptic-targeted therapies in oncology. Drugs disrupting synaptic machinery or modulating glutamatergic signaling might impair tumor growth or sensitize cancer cells to existing treatments. Given the critical role of synaptic proteins like VGluT1 and HOMER1 in these interfaces, they emerge as promising biomolecular targets for drug development.

The technological innovations applied, combining expansion microscopy with super-resolution and CLEM, exemplify state-of-the-art approaches to dissecting tumor microenvironments at near-molecular resolution. Such methodologies can be heralded as essential tools for future investigations into other cancer types and their interactions with the nervous system.

This seminal study offers a paradigm shift, revealing that SCLC cells can integrate into neural networks through bona fide synapses, thereby participating in complex cellular dialogues previously unappreciated in cancer research. As neuroscience and oncology converge, the characterization of tumor–neuron synapses heralds a new frontier with profound implications for cancer biology and therapeutic strategy.

Subject of Research: Synaptic interactions between neurons and small cell lung cancer cells.

Article Title: Functional synapses between neurons and small cell lung cancer.

Article References: Sakthivelu, V., Schmitt, A., Odenthal, F. et al. Functional synapses between neurons and small cell lung cancer. Nature (2025). https://doi.org/10.1038/s41586-025-09434-9

Image Credits: AI Generated

While previous investigations have documented neuron-cancer cell interactions within primary brain malignancies, such as gliomas, this research marks the first conclusive demonstration of such synaptic integration involving lung cancer cells that have migrated to the brain. The findings elaborate on how neural signaling pathways, previously underappreciated in metastatic contexts, actively contribute to cancer pathophysiology, opening doors to innovative therapeutic strategies aimed at disrupting these malign neural connections.

The heart of the study’s significance lies in the realization that tumor cells can co-opt the nervous system’s fundamental communication apparatus. This hijacking involves cancer cells forming bona fide synapses with neurons, leveraging electrical impulses to drive their own proliferation. The implications are profound, suggesting that pharmacological agents used to modulate neural signaling—primarily developed for neurological and psychiatric disorders—may be repurposed as targeted therapies against metastatic SCLC, which has been notoriously resistant to existing treatments.

Dr. Michelle Monje, a neurologist and Milan Gambhir Professor in Pediatric Neuro-Oncology at Stanford, emphasizes the clinical importance of this discovery. “Our data reveal that small cell lung cancer cells that metastasize to the brain aren’t simply surviving near neurons—they are electrically coupled to them, forming active synapses that are vital for tumor growth,” she explains. This insight represents a paradigm shift in cancer neuroscience, a field largely pioneered by Monje’s lab through their extensive work on primary brain tumors over the past decade and a half.

Collaborating closely with small cell lung cancer specialist Dr. Julien Sage and his team, the researchers built upon prior findings demonstrating that metastatic SCLC cells can morphologically and functionally mimic neurons. Dr. Sage’s 2023 research unveiled that these cancer cells grow neuron-like axonal protrusions and manipulate astrocytes—star-shaped glial cells in the brain—to secrete neuroprotective factors that nurture tumor survival. The current study extends this knowledge by showing that the cancer cells go beyond imitation to establish authentic synaptic connections with host neurons.

Small cell lung cancer constitutes about 15% of all lung cancer cases globally but accounts for a disproportionately high mortality rate, with over 200,000 deaths annually. A hallmark of this aggressive cancer subtype is its neuroendocrine origin; SCLC cells resemble both neurons and hormone-secreting endocrine cells, integrating signals from the nervous system. This unique biology may underlie their ability to exploit neural networks following brain metastasis.

Central to revealing the functional role of neuron-cancer synapses was the use of intricate experimental models, including mouse models engineered in Dr. Sage’s laboratory. These models allowed researchers to manipulate vagus nerve signaling—a critical parasympathetic pathway that connects the brain to the lungs—prior to tumor formation. Disruption of this neural input markedly suppressed tumor initiation and metastasis, underlying the significance of nerve activity during early tumor development. Notably, when nerve signaling was interrupted after tumors had established, the effect was diminished, implying distinct neural influences at different cancer progression stages.

The researchers also utilized optogenetics, a cutting-edge method that enables precise control of neural activity using light, to stimulate cortical neurons in live animals harboring implanted small cell lung cancer cells. This stimulation led to markedly increased tumor growth and invasiveness, underscoring the causative role of heightened neuronal activity. Further molecular analyses identified that neurons release growth factors upon activation, which, alongside synaptic electrical signaling, synergistically promote tumor expansion.

Microscopic and electrophysiological examinations provided compelling structural and functional evidence of the synaptic partnerships. Electron microscopy revealed that cancer cells in metastatic brain tumors physically participate in synapse formation with neurons. Patch-clamp recordings demonstrated that cancer cells generate electrical currents in response to neuronal signaling, confirming the biophysical reality of these synapses. Importantly, applying anti-epileptic drugs known to inhibit synaptic transmission significantly curtailed tumor growth, illuminating promising therapeutic avenues.

This study signifies a watershed moment in cancer biology by elucidating how tumor cells can integrate into the neural circuitry of the brain to fuel their malignancy. It challenges oncologists and neuroscientists alike to rethink cancer not only as a genetic or molecular disease but also as a disorder profoundly influenced by bioelectrical communication. These insights advocate for the inclusion of neuro-modulatory approaches alongside conventional chemotherapy and immunotherapy in combating metastatic SCLC.

Furthermore, the research emphasizes the growing importance of interdisciplinary collaboration. Expertise spanning neuro-oncology, electrophysiology, molecular genetics, and cancer biology coalesced to detail the novel interplay between neurons and metastatic cancer cells. Such integrative approaches will be essential to translate this knowledge into clinical interventions capable of improving patient survival and quality of life.

The discovery raises additional questions ripe for exploration: How universal is this phenomenon across other cancers with neurotropic tendencies? Can specific synaptic proteins or electrical signaling pathways be selectively targeted without disrupting normal brain function? What are the long-term impacts of modulating neural activity in the context of metastatic disease? Answering these will propel the emerging field of cancer neuroscience to new frontiers.

In summary, the revelation that small cell lung cancer cells metastasizing to the brain actively form functional synapses with neurons revolutionizes our conceptualization of tumor microenvironments and progression. This neuron-cancer electrical coupling not only drives tumor growth but also introduces novel molecular targets for intervention. As Dr. Monje aptly concludes, harnessing this understanding opens a promising and urgently needed path toward effective therapies against one of the most lethal lung cancer forms.

Subject of Research: Animals

Article Title: Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis

News Publication Date: 10-Sep-2025

Web References:
https://dx.doi.org/10.1038/s41586-025-09492-z

Keywords: Small cell lung cancer, Neurons, Cancer neuroscience, Brain metastasis, Synaptic signaling, Electrophysiology, Vagus nerve, Optogenetics, Tumor microenvironment, Neuroendocrine tumors, Anti-epileptic drugs, Tumor progression